Jonathan Aschoff
Stock Analyst at Roth MKM
(0.03)
# 4,728
Out of 4,993 analysts
440
Total ratings
29%
Success rate
-21.4%
Average return
Main Sectors:
Stocks Rated by Jonathan Aschoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDCX Medicus Pharma | Reiterated: Buy | $9 | $0.171 | +5,163.16% | 5 | Sep 9, 2026 | |
| APVO Aptevo Therapeutics | Reiterated: Buy | $21 | $1.81 | +1,060.22% | 12 | Sep 3, 2026 | |
| CELZ Creative Medical Technology Holdings | Reiterated: Buy | $20 | $1.01 | +1,890.05% | 9 | Aug 20, 2026 | |
| CLNN Clene | Reiterated: Buy | $30 | $4.54 | +560.79% | 7 | Aug 17, 2026 | |
| GTBP GT Biopharma | Reiterated: Buy | $3 | $7.18 | -58.22% | 6 | Aug 17, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Buy | $30 → $5 | $1.88 | +165.96% | 8 | Aug 10, 2026 | |
| REVB Revelation Biosciences | Reiterated: Buy | $16 | $0.9763 | +1,538.84% | 14 | Aug 7, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $21 | $11.67 | +79.95% | 18 | Aug 6, 2026 | |
| MBRX Moleculin Biotech | Reiterated: Buy | $31 | $0.5202 | +5,859.25% | 17 | Aug 4, 2026 | |
| NVCT Nuvectis Pharma | Rated: Buy | $20 → $33 | $21.98 | +50.14% | 3 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.3587 | +2,687.85% | 15 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.16 | +675.86% | 12 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $23.15 | +137.58% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 → $11 | $2.35 | +368.09% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $15 | $2.71 | +453.51% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.0001 | n/a | 8 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $2 | $0.0002 | n/a | 11 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $11 | $0.8738 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €2.78 | n/a | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.9483 | n/a | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.59 | $0.05 | n/a | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 | $3.40 | n/a | 9 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $36 | $39.28 | n/a | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 → $24 | $3.11 | n/a | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $620 → $500 | $0.0111 | n/a | 3 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $12.47 | n/a | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.03 | n/a | 1 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $30 | $0.1831 | n/a | 3 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.1511 | n/a | 5 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $8 | $0.0001 | n/a | 5 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.00001 | n/a | 4 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $7.84 | n/a | 1 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.0001 | n/a | 3 | Nov 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $1.24 | n/a | 17 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $3.85 | n/a | 3 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $26 | $2.29 | n/a | 2 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.7663 | n/a | 1 | Apr 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.0112 | n/a | 8 | Sep 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.69 | n/a | 12 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $0.27 | n/a | 17 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $205.49 | n/a | 5 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $5.51 | n/a | 10 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $124.65 | n/a | 14 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $0.9385 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $37.89 | n/a | 11 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $8.70 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $4.40 | n/a | 6 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $57.16 | n/a | 21 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $24.11 | n/a | 16 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $66.84 | n/a | 13 | Aug 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $489 | $798.17 | n/a | 18 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.372 | n/a | 4 | Nov 12, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $1.28 | n/a | 3 | Dec 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $64.06 | n/a | 3 | Oct 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $493.10 | n/a | 1 | Feb 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $1.43 | n/a | 1 | Jan 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.44 | n/a | 2 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $11 | $111.45 | n/a | 2 | Apr 16, 2012 |
Medicus Pharma
Sep 9, 2026
Reiterated: Buy
Price Target: $9
Current: $0.171
Upside: +5,163.16%
Aptevo Therapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $21
Current: $1.81
Upside: +1,060.22%
Creative Medical Technology Holdings
Aug 20, 2026
Reiterated: Buy
Price Target: $20
Current: $1.01
Upside: +1,890.05%
Clene
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $4.54
Upside: +560.79%
GT Biopharma
Aug 17, 2026
Reiterated: Buy
Price Target: $3
Current: $7.18
Upside: -58.22%
Tenax Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $30 → $5
Current: $1.88
Upside: +165.96%
Revelation Biosciences
Aug 7, 2026
Reiterated: Buy
Price Target: $16
Current: $0.9763
Upside: +1,538.84%
Zevra Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $21
Current: $11.67
Upside: +79.95%
Moleculin Biotech
Aug 4, 2026
Reiterated: Buy
Price Target: $31
Current: $0.5202
Upside: +5,859.25%
Nuvectis Pharma
Jul 6, 2026
Rated: Buy
Price Target: $20 → $33
Current: $21.98
Upside: +50.14%
May 26, 2026
Reiterated: Buy
Price Target: $10
Current: $0.3587
Upside: +2,687.85%
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $1.16
Upside: +675.86%
May 15, 2026
Reiterated: Buy
Price Target: $55
Current: $23.15
Upside: +137.58%
May 5, 2026
Rated: Buy
Price Target: $14 → $11
Current: $2.35
Upside: +368.09%
Apr 2, 2026
Reiterated: Buy
Price Target: $18 → $15
Current: $2.71
Upside: +453.51%
Jul 8, 2025
Reiterated: Buy
Price Target: $4 → $3
Current: $0.0001
Upside: n/a
Jun 4, 2025
Reiterated: Buy
Price Target: $9 → $2
Current: $0.0002
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $13 → $11
Current: $0.8738
Upside: n/a
May 12, 2025
Reiterated: Buy
Price Target: €12.00
Current: €2.78
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.9483
Upside: n/a
Sep 3, 2024
Reiterated: Buy
Price Target: $0.59
Current: $0.05
Upside: n/a
May 21, 2024
Rated: Buy
Price Target: $36
Current: $3.40
Upside: n/a
Mar 7, 2024
Reiterated: Buy
Price Target: $25 → $36
Current: $39.28
Upside: n/a
Mar 5, 2024
Reiterated: Buy
Price Target: $250 → $24
Current: $3.11
Upside: n/a
Dec 18, 2023
Reiterated: Buy
Price Target: $620 → $500
Current: $0.0111
Upside: n/a
Feb 27, 2023
Reiterated: Buy
Price Target: $14
Current: $12.47
Upside: n/a
Jun 15, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $1.03
Upside: n/a
Apr 28, 2022
Reiterated: Buy
Price Target: $4 → $30
Current: $0.1831
Upside: n/a
Oct 25, 2021
Reiterated: Buy
Price Target: $24
Current: $0.1511
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $2.5 → $8
Current: $0.0001
Upside: n/a
Aug 30, 2021
Reiterated: Buy
Price Target: $7
Current: $0.00001
Upside: n/a
Mar 11, 2021
Initiated Coverage: Buy
Price Target: $38
Current: $7.84
Upside: n/a
Nov 22, 2020
Reiterated: Buy
Price Target: $18
Current: $0.0001
Upside: n/a
Nov 17, 2020
Downgraded: Sell
Price Target: $8
Current: $1.24
Upside: n/a
Oct 14, 2020
Reiterated: Buy
Price Target: $14 → $11
Current: $3.85
Upside: n/a
Jul 14, 2020
Reiterated: Buy
Price Target: $13 → $26
Current: $2.29
Upside: n/a
Apr 20, 2020
Reiterated: Buy
Price Target: $9
Current: $0.7663
Upside: n/a
Sep 15, 2016
Reiterated: Buy
Price Target: $14
Current: $0.0112
Upside: n/a
Sep 13, 2016
Reiterated: Buy
Price Target: $4
Current: $1.69
Upside: n/a
Sep 9, 2016
Reiterated: Buy
Price Target: $55
Current: $0.27
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $29
Current: $205.49
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $24
Current: $5.51
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $92
Current: $124.65
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $26
Current: $0.9385
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $24 → $16
Current: $37.89
Upside: n/a
Aug 9, 2016
Reiterated: Sell
Price Target: $4 → $3
Current: $8.70
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $16
Current: $4.40
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $28
Current: $57.16
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: n/a
Current: $24.11
Upside: n/a
Aug 4, 2016
Reiterated: Buy
Price Target: $16 → $18
Current: $66.84
Upside: n/a
Mar 8, 2016
Initiated Coverage: Buy
Price Target: $489
Current: $798.17
Upside: n/a
Nov 12, 2015
Reiterated: Buy
Price Target: $5
Current: $0.372
Upside: n/a
Dec 8, 2014
Reiterated: Buy
Price Target: $16
Current: $1.28
Upside: n/a
Oct 24, 2014
Reiterated: Hold
Price Target: n/a
Current: $64.06
Upside: n/a
Feb 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $493.10
Upside: n/a
Jan 17, 2013
Downgraded: Sell
Price Target: $1
Current: $1.43
Upside: n/a
Jun 29, 2012
Reiterated: Buy
Price Target: n/a
Current: $25.44
Upside: n/a
Apr 16, 2012
Reiterated: Buy
Price Target: $13 → $11
Current: $111.45
Upside: n/a